Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

M. Fabbiani, S. Di Giambenedetto, E. Ragazzoni, M. Colafigli, M. Prosperi, R. Cauda, P. Navarra, A. De Luca

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology

    Nursing and Health Professions